1,206
Participants
Start Date
October 31, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
March 31, 2012
Vaccination with FAB-6011
One 0.5 mL injection of FAB-6011 trivalent influenza vaccine containing 6μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.
Vaccination with FluvalAB
One 0.5 mL injection of FLUVAL AB trivalent influenza vaccine containing 15μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.
Family Doctor's Office, Budapest
Family Doctor's Office, Budapest
Family Doctor's Office, Szentendre
Péter Vajer, Biatorbágy
Family Doctor's Office, Pilisvörösvár
Tibor Hrutka, Vecsés
Barna Bőze, Hatvan
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
INDUSTRY